The percentage of patients aged 18 and older with a diagnosis of atherosclerotic disease whose most recent LDL-C value is greater than 100 mg/dL and who are taking a lipid lowering agent
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting
-
1.14 Numerator
Patients with a current fill for a lipid lowering agent
-
1.15 Denominator
Patients with a diagnosis of atherosclerotic disease and whose most recent LDL-C is greater than 100 mg/dL.
-
Exclusions
General exclusions:
1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months
2. Patients who have been in a skilled nursing facility in the last 3 months
3. Patients who are terminally ill or in Hospice
4. Patient or provider feedback indicating allergy, intolerance or other contraindication to lipid lowering therapy anytime in the past
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative DataInitial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-